James Sabry, M.D., Ph.D., serves as Executive Vice President and Chief Business Officer and is responsible for business development, alliance management and corporate strategy.

Prior to joining BioMarin in 2024, James spent 14 years at Roche and Genentech, serving most recently as Executive Vice President and Global Head of Roche Partnering. During his tenure, he identified, evaluated, executed and managed transactions that bolstered the pipelines of both organizations. Earlier in his career, James was CEO and Chairman of Cytokinetics, a company he co-founded in 1998, as well as President and CEO of Arete Therapeutics. Before beginning his career in the biopharma industry, he held faculty positions at the University of California, San Francisco (UCSF) and Harvard Medical School. James serves on the Board of Directors of Ottimo Pharma.

James holds an M.D. from Queen’s University, completed his residency in neurology at Harvard Medical School and received his Ph.D. in Neuroscience from UCSF. He was a post-doctoral fellow in the Biochemistry Department at Stanford Medical School.

James lives in San Francisco with his wife and loves spending time with his family and friends. He is an avid road cyclist and loves reading.